Dennis Dooijes
Overview
Explore the profile of Dennis Dooijes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
2993
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thierry I, Muller S, Baas A, Dooijes D, van Loon R, Schoemaker A, et al.
Neth Heart J
. 2025 Jan;
33(2):46-54.
PMID: 39833651
Introduction: Current family screening approaches in dilated cardiomyopathy (DCM) depend on the presence or absence of a familial genetic variant, in which variant pathogenicity (i.e. benign or pathogenic) classification drives...
2.
Hassanzada F, Jansen M, van Lint F, Bosman L, Schmidt A, Dooijes D, et al.
Circ Genom Precis Med
. 2024 Dec;
17(6):e004561.
PMID: 39689185
Background: founder variants cause hypertrophic cardiomyopathy leading to heart failure and malignant ventricular arrhythmias. Exercise is typically regarded as a risk factor for disease expression although evidence is conflicting. Stratifying...
3.
Eichstaedt C, Maldonado-Velez G, Machado R, Balachandar S, Coulet F, Day K, et al.
medRxiv
. 2024 Dec;
PMID: 39649591
Purpose: Pulmonary arterial hypertension (PAH) is a rare disease that can be caused by pathogenic variants, most frequently in the bone morphogenetic protein receptor type 2 ( ) gene. We...
4.
de Frutos F, Ochoa J, Webster G, Jansen M, Remior P, Rasmussen T, et al.
J Am Heart Assoc
. 2024 Nov;
13(21):e036208.
PMID: 39494569
Background: Although genetic variants in are the most frequent cause of pediatric genetic dilated cardiomyopathy (DCM), there are no studies available describing this entity. We sought to describe clinical features,...
5.
Gomez-Arroyo J, Houweling A, Bogaard H, Aman J, Kitzmiller J, Porollo A, et al.
bioRxiv
. 2024 Sep;
PMID: 39345371
Rationale: Approximately 80% of patients with non-familial pulmonary arterial hypertension (PAH) lack identifiable pathogenic genetic variants. While most genetic studies of PAH have focused on predicted loss-of-function variants, recent approaches...
6.
Carrick R, Gasperetti A, Protonotarios A, Murray B, Laredo M, van der Schaaf I, et al.
Eur Heart J
. 2024 Jul;
45(32):2968-2979.
PMID: 39011630
Background And Aims: Pathogenic desmoplakin (DSP) gene variants are associated with the development of a distinct form of arrhythmogenic cardiomyopathy known as DSP cardiomyopathy. Patients harbouring these variants are at...
7.
Rekker L, Muller S, Gasperetti A, Bourfiss M, Oerlemans M, Cramer M, et al.
J Cardiovasc Magn Reson
. 2024 Jul;
26(2):101059.
PMID: 38986843
Background: While late gadolinium enhancement (LGE) is proposed as a diagnostic criterion for arrhythmogenic right ventricular cardiomyopathy (ARVC), the potential of LGE to distinguish ARVC from differentials remains unknown. We...
8.
Verheul L, van der Ree M, Groeneveld S, Mulder B, Christiaans I, Kapel G, et al.
Europace
. 2023 Nov;
25(11).
PMID: 37967257
Aims: During the diagnostic work-up of patients with idiopathic ventricular fibrillation (VF), next-generation sequencing panels can be considered to identify genotypes associated with arrhythmias. However, consensus for gene panel testing...
9.
Niskanen J, Ohlsson A, Ljungvall I, Drogemuller M, Ernst R, Dooijes D, et al.
Genome Med
. 2023 Sep;
15(1):73.
PMID: 37723491
Background: Dilated cardiomyopathy (DCM) is a life-threatening heart disease and a common cause of heart failure due to systolic dysfunction and subsequent left or biventricular dilatation. A significant number of...
10.
Jansen M, de Brouwer R, Hassanzada F, Schoemaker A, Schmidt A, Kooijman-Reumerman M, et al.
JACC Heart Fail
. 2023 Aug;
12(1):134-147.
PMID: 37565978
Background: MYH7 variants cause hypertrophic cardiomyopathy (HCM), noncompaction cardiomyopathy (NCCM), and dilated cardiomyopathy (DCM). Screening of relatives of patients with genetic cardiomyopathy is recommended from 10 to 12 years of...